NCT02798627 - Trial Of NS2359 For The Treatment of Cocaine Dependence | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

March 31, 2020

Study Completion Date

October 31, 2020

Conditions

Cocaine Use Disorder

Interventions

DRUG

NS2359

NS2359 is a small molecule which inhibits the reuptake of dopamine, norepinephrine and serotonin with equal affinity.

DRUG

placebo

Placebo pills identical in appearance to the NS2359 will be provided

Trial Locations (1)

University of Pennsylvania, Philadelphia